October 24th 2024
Nina Vadiei, PharmD, BCPP, a clinical associate professor at UT Austin and a clinical pharmacy specialist in psychiatry at San Antonio State Hospital, discusses her career as a psychiatric pharmacist.
Bootman honored as PPSI Distinguished Pharmacist of Year during APhA annual meeting
March 20th 2012J. Lyle Bootman, PhD, ScD, senior vice president for Health Sciences, dean and professor of Pharmacy, Medicine, and Public Health, University of Arizona, College of Pharmacy, was honored as the PPSI Distinguished Pharmacist of the Year, during PPSI’s annual breakfast, held during the American Pharmacists Association 2012 annual meeting in New Orleans.
FDA approves first oral contraceptive to treat heavy menstrual bleeding
March 15th 2012FDA has approved a new indication for estradiol valerate and estradiol valerate/dienogest (Natazia, Bayer HealthCare Pharmaceuticals) tablets for the treatment of heavy menstrual bleeding (HMB) that is not caused by any diagnosed conditions of the uterus.
Study: Adding prednisone to treatment improves rheumatoid arthritis symptoms
March 15th 2012Patients' rheumatoid arthritis symptoms improved after adding prednisone at the start of a methotrexate-based treatment strategy, according to research published in the March 6 issue of the Annals of Internal Medicine.
APP Pharmaceuticals releasing more preservative-free methotrexate
March 15th 2012Continuing to work with FDA to ease the ongoing shortage of injectable methotrexate, APP Pharmaceuticals this week released another 10,000 vials of preservative-free methotrexate (Methotrexate Injection), a drug used in the treatment of pediatric oncology and hematology
FDA approves first generic Lexapro to treat depression, anxiety disorder
March 14th 2012Teva/IVAX Pharmaceuticals gained FDA approval for the first generic version of Lexapro (Forest) to treat both depression and generalized anxiety disorder in adults. The company will have 180 days to exclusively sell the product.